Lv3
262 积分 2025-12-09 加入
Euglycaemic diabetic ketoacidosis as a complication of SGLT-2 inhibitors: epidemiology, pathophysiology, and treatment
2个月前
已完结
Effect of Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of SHR4640, a Selective Human Urate Transporter 1 Inhibitor
2个月前
已完结
Effect of Food on the Pharmacokinetics and Pharmacodynamics of a Single Oral Dose of SHR4640, a Selective Urate Transporter 1 Inhibitor, in Healthy Chinese Male Volunteers
2个月前
已完结
RUZINURAD FOR HYPERURICEMIA ASSOCIATED WITH PRIMARY GOUT: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED, PHASE 3 STUDY
2个月前
已完结
A Drug-Drug Interaction Study of a Novel Selective Urate Reabsorption Inhibitor, SHR4640, and Xanthine Oxidase Inhibitor, Febuxostat, in Patients With Primary Hyperuricemia
2个月前
已完结
10.1093/rheumatology/keab198
2个月前
已完结
Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis : A Multicenter Cohort Study
2个月前
已完结
Metformin in Type 2 Diabetes: Evidence for its Beneficial Effects on Frailty and Sarcopenia
4个月前
已完结
Tirzepatide for metabolic dysfunction-associated steatohepatitis: results from phase II clinical trials and perspectives
6个月前
已完结
皖公网安备34019202002308
